Authors: Leeksma, OC Kessler, JH Huijbers, IJG Ten Bosch, GJA Melief, CJM

Citation: Oc. Leeksma et al., BCR-ABL directed immunotherapy: A virtual reality?, LEUK LYMPH, 38(1-2), 2000, pp. 175-181

Authors: ten Bosch, GJA Leeksma, OC Melief, CJM

Citation: Gja. Ten Bosch et al., The BCR-ABL oncoprotein and immunological targeting - Vaccination for tumor prevention and therapy, BAS CLIN ON, 22, 2000, pp. 369-378

Authors: ten Bosch, GJA Kessler, JH Joosten, AM Bres-Vloemans, AA Geluk, A Godthelp, BC van Bergen, J Melief, CJM Leeksma, OC

Citation: Gja. Ten Bosch et al., A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct, BLOOD, 94(3), 1999, pp. 1038-1045

Authors: ten Bosch, GJA Kessler, JH Blom, J Joosten, AM Gambacorti-Passerini, C Melief, CJM Leeksma, OC

Citation: Gja. Ten Bosch et al., BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylation, BR J HAEM, 103(4), 1998, pp. 1109-1115